Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

UFS Dean presents lecture at the University of Cambridge

2009-10-09

Here at the main entrance (the "Chimney") of the Jesus College, after the certificate ceremony, are from far left: Prof. Barry Rider, Faculty of Law, University of Cambridge and Hosei Project leader, a group of students (Masters degree in Law) of the Faculty of Law from the Hosei University who received competency certificates after successfully completing the Hosei Summer School Project at the Jesus College, Prof. Henning, and Ms Li-hong Xing, Senior Research Fellow in the Centre for International Documentation on Organised and Economic Crime, Cambridge and Hosei Project Administrator.
Photo: Supplied

Prof. Johan Henning, Dean of the Faculty of Law at the University of the Free State (UFS) and Head of the Centre for Business Law at this faculty, delivered three papers during this year’s Cambridge International Symposium on Economic Crime that took place at Jesus College at the University of Cambridge in Cambridge. The theme of this 27th symposium was: “The enemy within – internal threats to the stability and integrity of financial institutions”.

Prof. Henning’s presentations were about: “Conflicts of interest and duty – a persistent threat”, “Data security and identity fraud” and “The responsibility of management for the prevention and control of financial crime-related risks”.

Over and above the three papers he delivered, Prof. Henning was also part of the secretariat of the symposium and he acted as chairperson at some of the workshops.

The UFS’s Faculty of Law was once again very much involved in the organisation and participation of the symposium. Since 1992, the Centre for Business Law of the Faculty of Law has been one of a few organising institutions of this popular and well-known symposium.

Prior to the symposium, Prof. Henning also acted as guest professor at the week-long Hosei Summer School Project that is presented by the Faculty of Law of the Hosei University (Tokyo Japan) in cooperation with the University of Cambridge. He presented two extended workshops for LLM students on International Business Law and Comparative Company Law.

Prof. Henning is also a Professorial Fellow at the Jesus College and a principal lecturer in International Mercantile Law at the Hosei University Summer School.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept